{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:04:40Z","timestamp":1649142280414},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.gastrohep.2014.05.004","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T02:15:36Z","timestamp":1403057736000},"page":"558-563","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Experiencia en el manejo de inmunosupresores con los f\u00e1rmacos inhibidores de proteasa frente al virus de la hepatitis C"],"prefix":"10.1016","volume":"37","author":[{"given":"Jes\u00fas","family":"Ruiz Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Romero Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Marrero \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Remedios","family":"Marqu\u00e9s Mi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Fern\u00e1ndez Meg\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Poveda Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2014.05.004_bib0005","first-page":"2060","article-title":"Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status","volume":"98","author":"Di Bisceglie","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0010","first-page":"35","article-title":"Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium","volume":"6","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clinthera.2012.12.017","article-title":"Telaprevir versus boceprevir in chronic hepatitis C: a meta-analysis of data from phase II and III trials","volume":"35","author":"Sitole","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0025","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.3748\/wjg.v19.i21.3199","article-title":"Sofosbuvir and ABT-450: Terminator of hepatitis C virus?","volume":"19","author":"Zeng","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1478-3231.2011.02714.x","article-title":"Hepatitis C virus treatment pre- and post-liver transplantation","volume":"32","author":"Roche","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0035","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/lt.23669","article-title":"Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation","volume":"19","author":"Pungpapong","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation, a multicenter experience","volume":"60","author":"Coilly","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0045","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.25653","article-title":"Review and management of drug interactions with boceprevir and telaprevir","volume":"55","author":"Kiser","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0050","first-page":"469","article-title":"Interacciones de los nuevos inhibidores de la proteasa para el tratamiento de la hepatitis C: telaprevir y boceprevir","volume":"36","author":"Izquierdo Garc\u00eda","year":"2012","journal-title":"Farm Hosp"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0055","unstructured":"Criterios y recomendaciones generales para el tratamiento con boceprevir y telaprevir de la hepatitis cr\u00f3nica C en pacientes infectados por el VIH, en trasplantados de h\u00edgado y en poblaci\u00f3n pedi\u00e1trica. Nota informativa AEMPS. 2011. [consultado 20 Ene 2014]. Disponible en: http:\/\/www.aemps.gob.es"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0060","unstructured":"Mathias A, Cornprospt M, Clemons D, Denning J, Symonds W. Gilead Sciences Inc. No Clinically Significant Pharmacokinetic Drug-Drug Interactions Between Sofosbuvir (GS-7977) and the Immunosuppressants Cyclosporine A or Tacrolimus in Healthy Volunteers. 63rd AASLD Annual Meeting. 2012. [consultado 20 Ene 2014]. Disponible en: www.natap.org"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24443","article-title":"Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus","volume":"54","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0070","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bcp.2012.07.032","article-title":"Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters","volume":"84","author":"Kunze","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0075","first-page":"11","article-title":"Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring","volume":"13","author":"Kuypers","year":"2008","journal-title":"Ann Transplant"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0080","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hep.25831","article-title":"Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers","volume":"56","author":"Hulskotte","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0085","unstructured":"Ficha t\u00e9cnica Rapamune (Sirolimus). [consultado 10 Jul 2013]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000273\/WC500046437.pdf"},{"key":"10.1016\/j.gastrohep.2014.05.004_bib0090","unstructured":"Ficha t\u00e9cnica Sovaldi (Sofosbuvir). [consultado 9 Abr 2014]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/002798\/WC500160597.pdf"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570514001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570514001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T04:57:05Z","timestamp":1538542625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570514001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0210570514001484"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2014.05.004","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experiencia en el manejo de inmunosupresores con los f\u00e1rmacos inhibidores de proteasa frente al virus de la hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2014.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. and AEEH y AEG. All rights reserved.","name":"copyright","label":"Copyright"}]}}